Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
In the SURMOUNT-1 clinical trial , people taking tirzepatide lost between 15% and 20.9% of their body weight over 72 weeks, depending on dose, compared to just 3.1% in the placebo group
Additionally, GLP-1 normally helps slow gastric emptying, enhancing satiety and reducing food intake, but these effects are diminished in diabetic individuals
doi: 10.1002/prp2.911 129 JinY.HouC.LiY.ZhengK.WangC
No, the main cause of fatigue is due to lifestyle modification
This segment will dive into the different indications for which the inhibitor is being developed, which would further provide insights into the potentially addressable patient population
US$ 23.31
US$ 25.29
US$ 20.75
